Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Setnikar

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Arzneimittel-Forschung|November 1, 1987
Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonistsF Makovec, M Bani, R Cereda, et al.
The Journal of Clinical Investigation|March 1, 1990
Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in manP Hildebrand, C Beglinger, K Gyr, et al.
Annals of Internal Medicine|July 4, 1998
The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trialJ Y Reginster, L Meurmans, B Zegels, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Arzneimittel-Forschung|November 1, 1987
Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonistsF Makovec, M Bani, R Cereda, et al.
The Journal of Clinical Investigation|March 1, 1990
Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in manP Hildebrand, C Beglinger, K Gyr, et al.
Annals of Internal Medicine|July 4, 1998
The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trialJ Y Reginster, L Meurmans, B Zegels, et al.
Pageof 10